Longeveron (LGVN) Misses Q3 EPS by 5c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. FIX
9. TSCO
10. BE

Go back to Longeveron (LGVN) Misses Q3 EPS by 5c

Longeveron Reports Third Quarter 2023 Results and Provides Corporate Update

November 10, 2023 7:30 AM EST

Top Line Results from CLEAR MIND Alzheimers disease Trial Affirm Safety Profile of Lomecel-B and Provide Efficacy Signal; Full Study Data Remains on Track to Share in Coming Weeks

Long-term Survival Data from ELPIS 1 Trial to be Presented at the 2023 Scientific Sessions of the American Heart Association

$4 Million in Equity Financing Secured in Registered Direct Offering

ELPIS II Phase 2 Trial of Lomecel-B in HLHS Continues Enrollment; Completion of Study Enrollment Anticipated in 2024

Company to Hold Conference Call and Webcast Today, November... More